An Overview of Thrombin Inhibitors in the Perspective of Structure-activity Relationships

被引：3
|
作者：
Wang, Jiangming [1 ]
Sun, Xiaojing [1 ]
Li, Na [1 ]
Sheng, Ruilong [2 ]
Guo, Ruihua [1 ,3 ,4 ]
机构：
[1] Shanghai Ocean Univ, Coll Food Sci & Technol, Shanghai 201306, Peoples R China
[2] Univ Madeira, CQM Cent Quim Madeira, Campus Penteada, P-9000390 Funchal, Portugal
[3] Shanghai Engn Res Ctr Aquat Prod Proc & Preservat, Shanghai 201306, Peoples R China
[4] Minist Agr, Lab Qual & Safety Risk Assessment Aquat Prod Stora, Shanghai 201306, Peoples R China
来源：
CURRENT MEDICINAL CHEMISTRY | 2023年 / 30卷 / 25期
基金：
中国国家自然科学基金;
关键词：
Antithrombotic; thrombin inhibitor; structure-activity relationship; pharmacokinetics; PROTEASE-ACTIVATED RECEPTORS; DESIGNING ALLOSTERIC REGULATORS; OPTIMIZING PLATELET INHIBITION; ORALLY BIOAVAILABLE SERIES; FACTOR XA INHIBITORS; BIOLOGICAL EVALUATION; ANTITHROMBOTIC COMPOUNDS; IN-VITRO; PART; SCUTELLAREIN DERIVATIVES;
D O I：
10.2174/0929867329666220906105200
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Thrombosis is one of the most important pathogenic factors related to cardiovascular diseases. Presently, thrombin inhibitors have gradually gained prominence in clinical practice due to their unique potential, such as dabigatran. Nevertheless, the risk of bleeding is not completely eliminated, and the threats of gastrointestinal bleeding are even increased in some cases. Therefore, developing new oral thrombin inhibitors with low side effects is urgent. In this paper, we summarized recent advances in the newly synthesized and isolated thrombin inhibitors from 2000 to 2019 and their structure-activity relationships (SARs) along with structure-dependent pharmacokinetic parameters, guiding the next generation of oral thrombin inhibitors.
引用
收藏
页码：2864 / 2930
页数：67
相关论文
共 50 条
  • [41] Structure-Activity Relationships of Glutamate Carboxypeptidase II (GCPII) Inhibitors
    Ferraris, D. V.
    Shukla, K.
    Tsukamoto, T.
    CURRENT MEDICINAL CHEMISTRY, 2012, 19 (09) : 1282 - 1294
  • [42] Structure-activity relationships(SAR) studies of CamK II inhibitors
    Kieres, Karolina
    Sala, Marina
    Monterrey, Gomez Isabel
    Bertamino, Alessia
    D'Ursi, Annamaria
    Ilario, Maddalena
    Grieco, Paolo
    Novellino, Ettore
    Campiglia, Pietro
    JOURNAL OF PEPTIDE SCIENCE, 2008, 14 (08) : 87 - 87
  • [43] HEPATIC EPOXIDE HYDRASE - STRUCTURE-ACTIVITY RELATIONSHIPS FOR SUBSTRATES AND INHIBITORS
    OESCH, F
    KAUBISCH, N
    JERINA, DM
    DALY, JW
    BIOCHEMISTRY, 1971, 10 (26) : 4858 - &
  • [44] Structure-Activity Relationships and Molecular Modeling of Sphingosine Kinase Inhibitors
    Baek, Dong Jae
    MacRitchie, Neil
    Anthony, Nahoum G.
    Mackay, Simon P.
    Pyne, Susan
    Pyne, Nigel J.
    Bittman, Robert
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (22) : 9310 - 9327
  • [45] Structure-activity relationships of acyloxyamidine cytomegalovirus DNA polymerase inhibitors
    Tucker, JA
    Clayton, TL
    Chidester, CG
    Schulz, MW
    Harrington, LE
    Conrad, SJ
    Yagi, Y
    Oien, NL
    Yurek, D
    Kuo, MS
    BIOORGANIC & MEDICINAL CHEMISTRY, 2000, 8 (03) : 601 - 615
  • [46] STRUCTURE-ACTIVITY RELATIONSHIPS
    MORLEY, JS
    GASTROENTEROLOGY, 1969, 56 (04) : 826 - &
  • [47] Synthesis and structure-activity relationships of novel benzofuran farnesyltransferase inhibitors
    Asoh, Kohsuke
    Kohchi, Masami
    Hyoudoh, Ikumi
    Ohtsuka, Tatsuo
    Masubuchi, Miyako
    Kawasaki, Kenichi
    Ebiike, Hirosato
    Shiratori, Yasuhiko
    Fukami, Takaaki A.
    Kondoh, Osamu
    Tsukaguchi, Toshiyuki
    Ishii, Nobuya
    Aoki, Yuko
    Shimma, Nobuo
    Sakaitani, Masahiro
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (06) : 1753 - 1757
  • [48] Design, synthesis and structure-activity relationships of novel ALS inhibitors
    Ren, TR
    Yang, HW
    Gao, X
    Yang, XL
    Zhou, JJ
    Cheng, FH
    PEST MANAGEMENT SCIENCE, 2000, 56 (03) : 218 - 226
  • [49] Synthesis and Quantitative Structure-Activity Relationships of Selective BCRP Inhibitors
    Marighetti, Federico
    Steggemann, Kerstin
    Hanl, Markus
    Wiese, Michael
    CHEMMEDCHEM, 2013, 8 (01) : 125 - 135
  • [50] First insight into structure-activity relationships of selective meprin β inhibitors
    Ramsbeck, Daniel
    Hamann, Antje
    Schlenzig, Dagmar
    Schilling, Stephan
    Buchholz, Mirko
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (11) : 2428 - 2431
12345